MedTrace Logo

Comparing Super High-flux and High-flux Dialyzer Performance Among Hemodialysis Patient With Sepsis : a Randomized Control Trial

NCT06989892 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 202

Last updated 2025-05-25

No results posted yet for this study

Summary

Comparing the efficacy of superhigh-flux dialyzer with high-flux dialyzer in ESKD patient who have sepsis to improve mortality and sepsis outcome, an open label randomized control trial.

Conditions

  • The Efficacy and Safety for Super High-flux Dialyzer in Case of Sepsis in ESKD
  • End Stage Kidney Disease (ESRD)
  • Sepsis

Interventions

DEVICE

Super High-flux dialyzer (Elisio 19HDx)

Dialysis with Super High-flux dialyzer for intervention group

DEVICE

High-flux dialyzer (Elisio 19H)

Dialysis with High-flux dialyzer for control group

Sponsors & Collaborators

  • Navamindradhiraj University

    lead OTHER

Principal Investigators

  • Punnawit Laungchuaychok, MD · Navamindradhiraj University

  • Wanjak Pongsittisak, MD · Navamindradhiraj University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-25
Primary Completion
2026-07-01
Completion
2026-10-01

Countries

  • Thailand

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06989892 on ClinicalTrials.gov